Clinical Trials Logo

Early Onset Neonatal Sepsis clinical trials

View clinical trials related to Early Onset Neonatal Sepsis.

Filter by:

NCT ID: NCT02886910 Withdrawn - Chorioamnionitis Clinical Trials

Chorioamnionitis: Observation of at Risk Infants vs Standard Care

CHORIS-RCT
Start date: October 2016
Phase: N/A
Study type: Interventional

This study evaluates the non-inferiority of a protocol of limited evaluation (complete blood count, blood culture) and clinical observation by standardized physical examination versus the algorithm suggested in the CDC's 2010 guidelines (limited evaluation, clinical observation and antibiotic therapy) in the management of asymptomatic infants born at term to mothers with suspected chorioamnionitis. The primary outcome of the study is the difference in the prevalence of sepsis-related symptoms between the two groups.

NCT ID: NCT02702297 Completed - Clinical trials for Preterm Premature Rupture of Membranes

Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes

MuMFI-PPROM
Start date: January 7, 2016
Phase:
Study type: Observational

The purpose of this study is to examine whether the value of vaginal fluid cytokine levels as well as computerized fetal ECG analysis are suitable clinical parameters to detect an imminent intra-amniotic inflammation with a high risk of fetal inflammatory response syndrome (FIRS) or a neonatal early onset sepsis (EOS) and whether these parameters can be determined on a daily basis in the clinical monitoring of pregnancies complicated by PPROM.

NCT ID: NCT02410486 Completed - Clinical trials for Infant, Newborn, Diseases

Early-Onset Sepsis an NICHD/CDC Surveillance Study

EOSII
Start date: April 2015
Phase:
Study type: Observational

This prospective surveillance study will be conducted over a 2 year period to determine current rates of Early-Onset Sepsis (EOS)/ Early-Onset Meningitis (EOM), associated pathogens, antimicrobial resistance, signs and symptoms and infant outcomes.

NCT ID: NCT00487019 Completed - Clinical trials for Early Onset Neonatal Sepsis

Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment

Start date: August 2006
Phase: N/A
Study type: Observational

A prospective two-center antibiotic regimen switch study will be conducted to compare the clinical efficacy of two antibiotic regimens - penicillin/gentamicin versus ampicillin/gentamicin - in the empirical treatment of early onset neonatal sepsis. The influence of either regimen on bowel colonization pattern and on the development of antibiotic resistance of gut microflora will also be assessed. The primary endpoint is the need for a change in antibacterial treatment within 72 hours of therapy, based on pre-defined criteria. Secondary endpoints will be the incidence rate and etiology of early and late onset neonatal sepsis and susceptibility pattern of causative microorganisms; mortality rate within 60 days; duration of hospitalization in NICU; duration of artificial ventilation; colonization pattern and susceptibility of colonizing bacteria (including resistance to empiric antibiotic regimen).